Federal funding for ibogaine clinical trials is justified by its therapeutic potential

From the articleUS advances first government-funded trials of psychedelic drug ibogaine | ReutersAlso in Pharmalittle: We're reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more